Ameriprise’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-41,781
| Closed | -$228K | – | 3990 |
|
|
2023
Q3 | $228K | Buy |
41,781
+10,600
| +34% | +$57.8K | ﹤0.01% | 3661 |
|
|
2023
Q2 | $212K | Buy |
+31,181
| New | +$212K | ﹤0.01% | 3713 |
|
|
2023
Q1 | – | Sell |
-66,392
| Closed | -$325K | – | 4039 |
|
|
2022
Q4 | $325K | Sell |
66,392
-1,106
| -2% | -$5.41K | ﹤0.01% | 3558 |
|
|
2022
Q3 | $973K | Sell |
67,498
-2,036
| -3% | -$29.3K | ﹤0.01% | 3127 |
|
|
2022
Q2 | $1.05M | Buy |
+69,534
| New | +$1.05M | ﹤0.01% | 3099 |
|